文献速递心外重症与机械循环支持

体外膜氧合生理因素影响脉搏血氧饱和度与动脉血氧饱和度差异

Extracorporeal Membrane Oxygenation Physiological Factors Influence Pulse Oximetry and Arterial Oxygen Saturation Discrepancies.
PubMed 文献 · Ann Thorac Surg · 2023-09-23

该回顾性研究分析了139例静脉-动脉ECMO和88例静脉-静脉ECMO成人患者的20053对SpO2-SaO2数据。静脉-静脉ECMO的SpO2-SaO2差异大于静脉-动脉ECMO(1.15% vs -0.35%,P < .001),隐匿性低氧血症更常见于静脉-静脉ECMO(65% vs 17%,P < .001)。中心静脉-动脉ECMO插管使SpO2低估SaO2 9.48%,单腔静脉-静脉ECMO插管使SpO2高估SaO2 25.43%,较高血管升压药剂量等效值和乳酸脱氢酶水平显著恶化SpO2-SaO2差异。

要点

  • 静脉-静脉ECMO患者隐匿性低氧血症风险高于静脉-动脉ECMO(65% vs 17%,P < .001)。
  • 中心静脉-动脉ECMO插管使SpO2低估SaO2 9.48%(95% CI,-17.1%至-1.79%;P = .02)。
  • 单腔静脉-静脉ECMO插管使SpO2高估SaO2 25.43%(95% CI,5.27%-45.6%;P = .03)。

核心结论

  • 静脉-静脉ECMO患者隐匿性低氧血症风险高于静脉-动脉ECMO。
  • 较高血管升压药需求和不同插管策略(中心静脉-动脉ECMO;单腔静脉-静脉ECMO)是两种ECMO模式下临床显著SpO2-SaO2差异的重要因素。

研究设计与样本

  • 回顾性分析一家三级学术ECMO中心的成人(年龄≥18岁)静脉-动脉或静脉-静脉ECMO患者。
  • 纳入氧饱和度≥70%且在10分钟内测量的SpO2-SaO2配对。
  • 隐匿性低氧血症定义为SaO2≤88%且时间匹配的SpO2≥92%。
  • 采用调整线性混合效应模型评估SpO2-SaO2差异与预选人口统计学和时间匹配实验室变量。
  • 血管升压药使用通过血管升压药剂量等效值量化。

主要发现

  • 共分析139例静脉-动脉ECMO和88例静脉-静脉ECMO患者的20053对SpO2-SaO2数据。
  • SpO2-SaO2差异在静脉-静脉ECMO为1.15%,大于静脉-动脉ECMO的-0.35%(P < .001)。
  • 81例患者(35%)在ECMO期间发生隐匿性低氧血症,静脉-静脉ECMO为65%,高于静脉-动脉ECMO的17%(P < .001)。
  • 线性混合效应模型中,中心静脉-动脉ECMO较外周静脉-动脉ECMO使SpO2低估SaO2 9.48%(95% CI,-17.1%至-1.79%;P = .02)。
  • 线性混合效应模型中,单腔静脉-静脉ECMO较双腔静脉-静脉ECMO使SpO2高估SaO2 25.43%(95% CI,5.27%-45.6%;P = .03)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cannulation strategy, vasopressors, and hemolysis are important physiological factors that influence hemodynamics in extracorporeal membrane oxygenation (ECMO). We hypothesized these factors influence the discrepancy between oxygen saturation measured by pulse oximetry (Spo2) and arterial blood gas (Sao2) in patients on ECMO. METHODS: We retrospectively analyzed adults (aged ≥18 years) on venoarterial or venovenous ECMO at a tertiary academic ECMO center. Spo2-Sao2 pairs with oxygen saturation ≥70% and measured within 10 minutes were included. Occult hypoxemia was defined as Sao2 ≤88% with a time-matched Spo2 ≥92%. Adjusted linear mixed-effects modeling was used to assess the Spo2-Sao2 discrepancy with preselected demographics and time-matched laboratory variables. Vasopressor use was quantified by vasopressor dose equivalences. RESULTS: Of 139 venoarterial-ECMO and 88 venovenous-ECMO patients, we examined 20,053 Spo2-Sao2 pairs. The Spo2-Sao2 discrepancy was greater in venovenous-ECMO (1.15%) vs venoarterial-ECMO (-0.35%, P < .001). Overall, 81 patients (35%) experienced occult hypoxemia during ECMO. Occult hypoxemia was more common in venovenous-ECMO (65%) than in venoarterial-ECMO (17%, P < .001). In linear mixed-effects modeling, Spo2 underestimated Sao2 by 9.48% in central vs peripheral venoarterial-ECMO (95% CI, -17.1% to -1.79%; P = .02). Higher vasopressor dose equivalences significantly worsened the Spo2-Sao2 discrepancy (P < .001). In linear mixed-effects modeling, Spo2 overestimated Sao2 by 25.43% in single lumen-cannulated vs double lumen-cannulated venovenous-ECMO (95% CI, 5.27%-45.6%; P = .03). Higher vasopressor dose equivalences and lactate dehydrogenase levels significantly worsened the Spo2-Sao2 discrepancy (P < .001). CONCLUSIONS: Venovenous-ECMO patients are at higher risk for occult hypoxemia compared with venoarterial-ECMO. A higher vasopressor requirement and different cannulation strategies (central venoarterial-ECMO; single-lumen venovenous-ECMO) were significant factors for clinically significant Spo2-Sao2 discrepancy in both ECMO modes.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Kalra A, Shou BL, Zhao D, et al. Extracorporeal Membrane Oxygenation Physiological Factors Influence Pulse Oximetry and Arterial Oxygen Saturation Discrepancies. Ann Thorac Surg. 2023. PMID: 37748529. doi:10.1016/j.athoracsur.2023.09.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。